Funding of £5m will create new jobs in Norfolk
Thirty new laboratories and offices for 300 research scientists are to be built in Norfolk, UK
The new development will be based at Norwich Science Park and provide facilities for start-up and expanding businesses.
BBSRC will provide £500,000 as well as the land and buildings to host the new facilities, with £1.4m coming from the East of England Development Agency (EEDA), £1m from the Greater Norwich Development Partnership (GNDP), £500,000 from NRP partner the University of East Anglia (UEA), and the remainder from other NRP partners.
The new facilities, to be opened in July, will be managed by a new joint venture company called Colney Innovations (CIL).
David Parfrey, BBSRC director of finance and director of CIL, said: "The research carried out by the 2,000 scientists already working at Norwich Science Park is world-class and it makes absolute sense to create a facility on this site where the results of such research can be taken through to applications."
Prof Douglas Kell, chief executive of BBSRC, added: "The Norwich Research Park is home to three world-class BBSRC institutes: the John Innes Centre, the Institute of Food Research and The Genome Analysis Centre. This new facility will play a key role in helping our scientists, and others, to translate their excellent science into products to benefit the economy and people of the UK."
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
PFAS regulation pressure intensifies as new Chemspec whitepaper urges early industry action
Read moreA new whitepaper launched at Chemspec Europe 2026 warns that tightening global PFAS regulation could trigger major supply chain and compliance challenges for chemical manufacturers unless companies begin transition planning now
Trending Articles
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Sustainability
PFAS regulation pressure intensifies as new Chemspec whitepaper urges early industry action
A new whitepaper launched at Chemspec Europe 2026 warns that tightening global PFAS regulation could trigger major supply chain and compliance challenges for chemical manufacturers unless companies begin transition planning now
Digital
Cytiva launches next-generation Biacore 8 SPR systems for accelerated drug discovery
The company has introduced its new Biacore 8S and 8S+ surface plasmon resonance systems, combining high-throughput screening, molecular characterisation and automated workflows to support faster and more confident drug discovery
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Drug Delivery
No more needles? How intradermal delivery could transform vaccine access
A new review has put forward novel needle-free Intradermal (ID) delivery formats as an effective alternative to traditional administration using needles, with the technologies demonstrating improved immunisation coverage and cost savings
Research & Development
Concept Life Science and OpenBench team up on AI-driven hit discovery platform for biotechs
The pair will combine AI-powered virtual screening, medicinal chemistry and in-vitro validation in a fee-for-success model designed to accelerate hit identification and reduce early-stage drug discovery risk for biotech firms
Microbiology
AMR Bio launches as clinical-phase biotech to advance Phase III-ready topical antimicrobial XF-73
The firm has announced its launch as a clinical-stage biotechnology company focused on advancing XF-73 Nasal, a first-in-class topical gel, towards Phase III development and commercialisation as a pre-surgical decolonisation treatment